Anti-tumour activity of low molecular weight heparin doxorubicin nanoparticles for histone H1 high-expressive prostate cancer PC-3M cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Anti-tumour activity of low molecular weight heparin doxorubicin nanoparticles for histone H1 high-expressive prostate cancer PC-3M cells

Published:2019-02 Issue: Volume:295 Page:102-117
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Zhang Shuang,Li Zhan-Tao,Liu Man,Wang Jing-Ru,Xu Mei-Qi,Li Zhuo-Yue,Duan Xiao-Chuan,Hao Yan-Li,Zheng Xiu-Chai,Li Hui,Feng Zhen-Han,Zhang Xuan

Funder

National Key Research and Development Program of China

National Natural Science Foundation of China

Innovation Team of the Ministry of Education

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference71 articles.

1. Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery;Torchilin;Nat. Rev. Drug Discov.,2014

2. Nanocarriers as an emerging platform for cancer therapy;Peer;Nat. Nanotechnol.,2007

3. Ligand-targeted drug delivery;Srinivasarao;Chem. Rev.,2017

4. Antibodies and associates: partners in targeted drug delivery;Kennedy;Pharmacol. Ther.,2017

5. Nuclear drug delivery for cancer chemotherapy;Sui;J. Control. Release,2011

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Zinc oxide nanoparticles with catalase-like nanozyme activity and near-infrared light response: A combination of effective photodynamic therapy, autophagy, ferroptosis, and antitumor immunity;Acta Pharmaceutica Sinica B;2024-07

2. Multifunctional ZnO@DOX/ICG-LMHP Nanoparticles for Synergistic Multimodal Antitumor Activity;Journal of Functional Biomaterials;2024-01-30

3. Vascular endothelial growth factor (VEGF) delivery approaches in regenerative medicine;Biomedicine & Pharmacotherapy;2023-10

4. Targeted Delivery of Doxorubicin as a Potential Chemotherapeutic Agent;Current Drug Delivery;2023-08

5. Stimuli-responsive heparin-drug conjugates co-assembled into stable nanomedicines for cancer therapy;Acta Biomaterialia;2023-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3